Titles and Roles
- Senior Researcher Associate
- Emory's Whitehead Biomedical Research Building
- Research Program
- Discovery and Developmental Therapeutics
John Codington, senior research associate, hopes to develop a better, more reliable and consistent way to detect most cancers, preferably at the earliest stages.
Dr. Codington's journey has taken him full circle, from Atlanta, where his family moved when he was one, to college at Emory, to the University of Virginia’s malaria research program, to the National Institutes of Health, to Europe, to faculty positions at Cornell and Harvard, to private biotech companies, and back to Emory.
Dr. Codington's primary research concerns the chemical changes in cell surface glycoproteins associated with immunoresistance in tumor cells, and his goal is to develop a diagnostic assay of sera to detect the presence of a carcinoma (cancer found in epithelial tissues). He hopes to develop a better, more reliable, and consistent way to detect most cancers, preferably at the earliest stages. "The test must be robust and suitable for clinical use," he says.